[1] |
Iaccarino C, Carretta A, Nicolosi F, et al. Epidemiology of severe traumatic brain injury[J]. J Neurosurg Sci, 2018, 62(5): 535-541.
|
[2] |
Hazeldine J, Hampson P, Lord JM. The impact of trauma on neutrophil function[J]. Injury, 2014, 45(12): 1824-1833.
|
[3] |
Osler T, Cook A, Glance LG, et al. The differential mortality of Glasgow coma score in patients with and without head injury[J]. Injury, 2016, 47(9): 1879-1885.
|
[4] |
靳佳敏,马翠红,范昆鹏,等.血浆NLR、PLR及其联合指标对脑梗死溶栓患者预后的预测价值[J].临床荟萃, 2020, 35(3): 228-232.
|
[5] |
黎开宇,钟晖东,张海冰,等.术前中性粒细胞与淋巴细胞比值对重度颅脑外伤预后的预测价值[J].海南医学, 2018, 29(13): 1814-1817.
|
[6] |
Büki A, Barzó P, Demeter B, et al. Guidelines for the treatment of traumatic brain injury-2017[J]. Ideggyogy Sz, 2017, 70(7-8): 223-245.
|
[7] |
Karibe H, Hayashi T, Narisawa A, et al. Clinical characteristics and outcome in elderly patients with traumatic brain injury: for establishment of management strategy[J]. Neurol Med Chir (Tokyo), 2017, 57(8): 418-425.
|
[8] |
Caterino JM, Raubenolt A, Cudnik MT. Modification of Glasgow coma scale criteria for injured elders[J]. Acad Emerg Med, 2011, 18(10): 1014-1021.
|
[9] |
McIntyre A, Mehta S, Aubut J, et al. Mortality among older adults after a traumatic brain injury: a meta-analysis[J]. Brain Inj, 2013, 27(1): 31-40.
|
[10] |
张小兵,高亮,吉宋泉,等.中性粒细胞-淋巴细胞比值在颅脑损伤预后评估中的作用[J].中国临床神经外科杂志, 2020, 25(7): 441-442, 446.
|
[11] |
Sulhan S, Lyon KA, Shapiro LA, et al. Neuroinflammation and blood-brain barrier disruption following traumatic brain injury: Pathophysiology and potential therapeutic targets[J]. J Neurosci Res, 2020, 98(1): 19-28.
|
[12] |
Nguyen HX, O’Barr TJ, Anderson AJ. Polymorphonuclear leukocytes promote neurotoxicity through release of matrix metalloproteinases, reactive oxygen species, and TNF-alpha[J]. J Neurochem, 2007, 102(3): 900-912.
|
[13] |
Roth TL, Nayak D, Atanasijevic T, et al. Transcranial amelioration of inflammation and cell death after brain injury[J]. Nature, 2014, 505(7482): 223-228.
|
[14] |
Hofstetter HH, Sewell DL, Liu F, et al. Autoreactive T cells promote post-traumatic healing in the central nervous system[J]. J Neuroimmunol, 2003, 134(1-2): 25-34.
|
[15] |
Schwartz M, Moalem G. Beneficial immune activity after CNS injury: prospects for vaccination[J]. J Neuroimmunol, 2001, 113(2): 185-192.
|
[16] |
Lattanzi S, Brigo F, Trinka E, et al. Neutrophil-to-lymphocyte ratio in acute cerebral hemorrhage: a system review[J]. Transl Stroke Res, 2019, 10(2): 137-145.
|
[17] |
Ploplis VA, Donahue DL, Sandoval-Cooper MJ, et al. Systemic platelet dysfunction is the result of local dysregulated coagulation and platelet activation in the brain in a rat model of isolated traumatic brain injury[J]. J Neurotrauma, 2014, 31(19): 1672-1675.
|
[18] |
Nekludov M, Bellander BM, Blombäck M, et al. Platelet dysfunction in patients with severe traumatic brain injury[J]. J Neurotrauma, 2007, 24(11): 1699-1706.
|
[19] |
Yuan Q, Yu J, Wu X, et al. Prognostic value of coagulation tests for in-hospital mortality in patients with traumatic brain injury[J]. Scand J Trauma Resusc Emerg Med, 2018, 26(1): 3.
|
[20] |
Dijkland SA, Foks KA, Polinder S, et al. Prognosis in moderate and severe traumatic brain injury: a systematic review of contemporary models and validation studies[J]. J Neurotrauma, 2020, 37(1): 1-13.
|